Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Enterprise Value (2025 - 2026)

Updated

Translational Development Acquisition (TDACU) reported Enterprise Value of $305.9 million for Q2 2026, up 36.0% from $224.95 million a year earlier and up 32.0% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Enterprise Value (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Translational Development Acquisition's Enterprise Value came in at $305.8 million, up 36.3% year-over-year; for FY2025, it was $229.78 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $231.76 million (Q1 2026), $229.78 million (Q4 2025) and $226.7 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 305.90 Mn
Mar 31, 2026 231.76 Mn
Dec 31, 2025 229.78 Mn
Sep 30, 2025 226.70 Mn
Jun 30, 2025 224.95 Mn
Mar 31, 2025 220.62 Mn
API Access

Translational Development Acquisition Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=TDACU&period=max&api_key=YOUR_API_KEY